In mammals, genetically-directed cell labeling technologies have not yet been applied to the morphologic analysis of neurons with very large and complex arbors, an application that requires extremely sparse labeling and that is only rendered practical by limiting the labeled population to one or a few predetermined neuronal subtypes.
Methods and Findings
In the present study we have addressed this application by using CreER technology to non-invasively label very small numbers of neurons so that their morphologies can be fully visualized. Four lines of IRES-CreER knock-in mice were constructed to permit labeling selectively in cholinergic or catecholaminergic neurons [choline acetyltransferase (ChAT)-IRES-CreER or tyrosine hydroxylase (TH)-IRES-CreER], predominantly in projection neurons [neurofilament light chain (NFL)-IRES-CreER], or broadly in neurons and some glia [vesicle-associated membrane protein2 (VAMP2)-IRES-CreER]. When crossed to the Z/AP reporter and exposed to 4-hydroxytamoxifen in the early postnatal period, the number of neurons expressing the human placental alkaline phosphatase reporter can be reproducibly lowered to fewer than 50 per brain. Sparse Cre-mediated recombination in ChAT-IRES-CreER;Z/AP mice shows the full axonal and dendritic arbors of individual forebrain cholinergic neurons, the first time that the complete morphologies of these very large neurons have been revealed in any species.
Citation: Rotolo T, Smallwood PM, Williams J, Nathans J (2008) Genetically-Directed, Cell Type-Specific Sparse Labeling for the Analysis of Neuronal Morphology. PLoS ONE 3(12): e4099. https://doi.org/10.1371/journal.pone.0004099
Editor: Eshel Ben-Jacob, Tel Aviv University, Israel
Received: September 23, 2008; Accepted: December 2, 2008; Published: December 31, 2008
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: Howard Hughes Medical Institute, National Eye Institute (NIH).
Competing interests: The authors have declared that no competing interests exist.
A central organizing principle in all nervous systems is the division of neurons into different classes based on their distinctive dendritic and/or axonal morphologies. This principle was first appreciated over a century ago following the systematic analysis of individual neuronal morphologies in Golgi stained preparations . Over the past several decades, methods for visualizing the morphologies of individual neurons have been developed that are based on intracellular injection of tracers such as horse-radish peroxidase (HRP), neurobiotin or biocytin, and dextran-conjugated fluorescent dyes, or bombardment with particles coated by carbocyanine dyes –. Labeling by intracellular injection has the virtue that the micro-pipette used for cell filling can also be used to characterize the neuron electrophysiologically, thereby generating a dataset that links morphological and physiological properties [e.g. ref. 6].
A second general strategy for visualizing neuronal morphology relies on the selective expression of genes coding for enzymes or fluorescent proteins. These genes can be introduced acutely into target neurons by viral infection, electroporation, or particle bombardment –. Although these methods are limited by the requirement for mechanical access to the neurons of interest and by the stochastic nature of cell targeting, they have the virtue of being relatively rapid and applicable to virtually any experimental animal. Alternatively, reporter genes can be introduced into the germline or into fertilized embryos in those model organisms amenable to such manipulation (nematodes, Drosophila, zebrafish, Xenopus, or mice). Among germline techniques for cell marking, ‘mosaic analysis with a repressible cell marker’ (MARCM) in Drosophila, and its cousin ‘mosaic analysis with a double marker’ (MADM) in mice, are conceptually the most general as they produce a sparse collection of cells distinguished by the exchange of a pre-defined chromosome arm that can carry an arbitrary set of genetic markers , .
In the mouse, genetically directed neuronal labeling has typically been achieved by the selective expression of a fluorescent protein or enzyme under the direct control of a cell-type-specific promoter or under the indirect control of a pharmacologically-regulated fusion between Cre recombinase and a mutated estrogen receptor ligand-binding domain [CreER; 13]–. Several implementations of the sparse labeling approach have taken advantage of the serendipitous observation that transgenes driven by the Thy-1 promoter often show strong position effects that restrict expression to small subsets of neurons, with the cell type and labeling density being distinctive for a given transgenic line –. Other implementations have used BAC transgenes to produce fluorescent proteins or Cre recombinase in a cell type specific manner , .
The mouse studies reported thus far have not applied genetic labeling technologies to the morphologic analysis of neurons with large and complex arbors, an application that requires extremely sparse labeling and that is only rendered practical by limiting the labeled population to one or a few predetermined neuronal subtypes. In the present study we have addressed this application by developing and characterizing a series of mouse lines that express CreER in distinct neuronal subsets and we have used these lines in conjunction with a plasma membrane-anchored alkaline phosphatase reporter to visualize the morphologies of large CNS neurons.
Construction of IRES-CreER knock-in lines
To achieve sparse cell-type specific Cre-mediated recombination, we chose a strategy in which an internal ribosome entry site (IRES) and a CreER coding region were inserted into the 3′ untranslated region (UTR) of three genes that are expressed in defined subsets of neurons and one gene that is expressed in neurons and a subset of glia (Figure 1). For the former category we used the genes coding for choline acetyltransferase (ChAT; cholinergic neurons), tyrosine hydroxylase (TH; catecholaminergic neurons), and neurofilament light chain (NFL; projection neurons). For the latter category we used the gene coding for vesicle-associated membrane protein 2 (VAMP2).
For each knock-in allele, a cassette consisting of an IRES-CreER, the pBR322 Tetracycline resistance gene (TetR), and an Frt-flanked phosphoglycerate kinase promotor neomycin resistance gene (FNF) was inserted into the 3′ untranslated region of the target gene as indicated. The PGK-neo casette was subsequently removed in vivo by Flp recombinase. The sizes of the homology regions used for the targeting constructs were: ChAT, 9.5 kb; NFL, 7.0 kb; TH, 9.2 kb; and VAMP2, 9.1 kb. For Southern blot hybridization, the probes indicated beneath the maps of the targeted loci were used, and genomic DNAs from the four groups of targeted ES cells and germ-line transmitted mice were cleaved with the following restriction enzymes: ChAT, Stu I and BamH I; NFL, EcoR V; TH, BamH I; and VAMP2, Nco I.
For each of the four target genes, IRES-CreER sequences were inserted by homologous recombination in embryonic stem (ES) cells. We chose this approach rather than conventional or bacterial artificial chromosome (BAC) transgenesis because we presumed that a knock-in allele would have the greatest likelihood of precisely recapitulating the expression pattern of the endogenous gene. Although constructing gene-targeted mouse lines is more labor intensive than constructing BAC transgenic mice, it has the virtue that only one knock-in mouse line needs to be characterized for each construct. In contrast, in a transgenic approach, multiple lines are typically characterized for each construct to assess the effects of line-to-line variation in transgene structure, copy number, and integration site, as this variation can affect the expression level or lead to variegated expression. A potential disadvantage of the knock-in strategy is that the insertion of foreign sequences within the 3′ UTR could compromise the function of the target gene, for example by altering mRNA transport, stability, or translation efficiency. In the present instance, no phenotypic effects were apparent for any of the IRES-CreER alleles in the heterozygous state or for the ChAT-IRES-CreER, NFL-IRES-CreER, or TH-IRES-CreER alleles in the homozygous state. However, homozygosity for the VAMP2-IRES-CreER allele appears to be lethal.
The strategy of inserting IRES-CreER sequences into the 3′ UTR places the exogenous DNA segment at a greater distance from the start site of transcription than would insertion of CreER sequences in the 5′ UTR, a design feature that, together with Flp-mediated excision of the Frt-flanked Phospho-glycerate kinase (PGK) promotor-neomycin resistance (neo) selectable marker (‘FNF’), should minimize perturbations in gene expression in the targeted allele (Figure 1). For the present set of four knock-in alleles, the distances between the start site of transcription and the point of insertion of the IRES-CreER cassette are: 57 kb (ChAT), 3.5 kb (NFL), 6.8 kb (TH), and 2.0 kb (VAMP2). As shown in Figure 1, the IRES-CreER-FNF cassette also includes a bacterial tetracycline resistance gene (TetR) 3′ of the CreER sequences, a selectable marker that facilitated the identification of bacterial colonies harboring the plasmids into which this cassette had been inserted.
Cell type specificity of IRES-CreER expression
To characterize the cell type specificity of IRES-CreER expression, each targeted line was crossed to the Z/AP reporter line . In the absence of Cre-mediated recombination, the Z/AP locus ubiquitously expresses a beta-galactosidase-neo fusion protein (beta-geo). Cre-mediated recombination excises the beta-geo coding sequence and simultaneously activates expression of human placental alkaline phosphatase (AP), a heat-stable enzyme that localizes to the plasma membrane via a GPI anchor , . Previous work has shown that activation of the Z/AP reporter in neurons leads to the efficient accumulation of AP on individual axons and dendrites, which can be visualized by histochemical staining .
Mice from the four IRES-CreER;Z/AP lines were treated with a single dose of 4-hydroxytamoxifen (4HT) during the first two postnatal weeks, and >1 month later tissues were harvested and the distribution of AP revealed by histochemical staining. The specificities of the NFL-IRES-CreER and ChAT-IRES-CreER lines were analyzed in flatmounts of adult retina. As seen in Figure 2A, AP-labeling in NFL-IRES-CreER;Z/AP mice is confined to retinal ganglion cells, each of which projects an axon to the optic disc, and less frequently to horizontal cells (not shown in Figure 2A), the two principal cell types in the retina that express neurofilament . As seen in Figure 2C and D, AP labeling in ChAT-IRES-CreER;Z/AP mice is confined to cholinergic (starburst) amacrine cells, recognizable by their characteristic pinwheel morphology; these are the only cells in the retina that express choline acetyltransferase . In the brain and retina, AP labeling in VAMP2-IRES-CreER;Z/AP mice is observed in a wide variety of neurons as well as in glia (Figure 2B and data not shown). Thus far, we have not observed TH-IRES-CreER mediated Z/AP recombination in the retina, a failure that we attribute to the paucity of dopaminergic amacrine cells [(450 cells per mouse retina; 27]. However, as described below, labeling in the brain in this line is consistent with expression in catecholaminergic neurons.
The cell-type specificity of each line was tested by crossing to the Z/AP reporter and inducing sparse recombination with 4HT. A, In the retina, the NFL-IRES-CreER line exhibits Cre-mediated recombination in retinal ganglion cells, each of which has a single axon projecting to the optic disc, and in horizontal cells; the image shown here shows only retinal ganglion cells. B, in the brain, the VAMP2-IRES-CreER line exhibits Cre-mediated recombination in both neurons and glia. C and D, in the retina, the ChAT-IRES-CreER line exhibits Cre-mediated recombination exclusively in cholinergic (starburst) amacrine cells. The region boxed in C is shown at higher magnification in D. Scale bars: 0.5 mm in A and B; 1 mm in C.
Sparse genetic labeling for visualizing neuronal morphology
Figure 3A shows an example of sparse AP-labeling of cortical pyramidal neurons (or parts thereof) in a 200 um thick vibratome section from an NFL-IRES-CreER;Z/AP brain. Bright field images at a single focal plane are shown in Figure 3B–D, and demonstrate the clarity with which fine processes are visualized by AP histochemistry. The scarcity of labeled neurons is evident from the large regions of unlabeled cortex.
A, 200 um vibratome section from the brain of an NFL-IRES-CreER;Z/AP mouse injected at P0 with 0.2 mg 4HT. In this section, three large neurons (or parts of neurons) are labeled in one hemisphere of the cerebral cortex. B–D, enlarged bright field images at one Z-plane for each of the three neurons. Scale bar: 0.5 mm.
AP-labeled neurons can be fully reconstructed in 3-dimensions with NIH-Image or equivalent software, as demonstrated in a survey of retinal neurons . In the present study, we have limited the reconstruction to a two-dimensional projection in the plane of each thick section, an image that we will refer to hereafter as a “tracing” rather than a “reconstruction” to distinguish it from a full three-dimensional reconstruction. This more limited analysis has the virtue of technical simplicity, while still illustrating (albeit, in projection) the principal morphologic features of the neurons under analysis. Examples of neuronal tracings together with samples of the corresponding Z-stack images from which they were obtained are shown in Figure 4. Figure 4C shows a tracing of the cortical pyramidal neuron in the 200 um section shown in Figure 3B. The remaining panels in Figure 4 - which show a multipolar cortical neuron (Figure 4A), cerebellar mossy fibers (Figure 4B), cerebellar granule cells with parallel fibers (Figure 4D), and a small cortical pyramidal neuron (Figure 4E) - are from sections of 300 um thickness. The tracings were prepared using Z-stacked images sampled at either 1 or 2 um intervals. As seen in Figures 3 and 4, AP intensity varies systematically with the type and location of neuronal processes, being heaviest in regions, such as the soma-proximal dendrites and apical process of pyramidal neurons, that are observed to be more intensely labeled in neurobiotin filling experiments .
A, Multipolar neuron in the inferior cerebral cortex. B, Mossy fibers in the cerebellum. C, The cortical pyramidal cell shown in Figure 3B. D, Cerebellar granule cells. E, a compact cortical pyramidal cell. A–D are from NFL-IRES-CreER;Z/AP brains, and E is from a ChAT-IRES-CreER;Z/AP brain; the tracing of the cell in E is shown at lower magnification in Figure 5J. A, B, D, and E are traced from 300 um thick sections, and samples from the corresponding Z-series bright field images are shown. C is traced from a 200 um thick section; a sample from the Z-series image is shown in Figure 3B. Scale bars: 0.2 mm.
For retinal ganglion cells, the CreER;Z/AP method labels dendrites, axons, and axon arbors (the latter in retino-recipient areas in the brain) in patterns that closely match those obtained by classical labeling methods such as diI and neurobiotin filling (Figure 2B; ref. 15; and T.R., T. Badea, and J.N., unpublished observations). As described below, among neurons with complex axonal arbors extending several millimeters, we observed no discernable variation in staining intensity within the axonal arbor. These data suggest that the >1 month delay between 4HT injection and sacrifice produces a roughly uniform distribution of AP over the entire extent of an axonal or dendritic arbor.
Visualizing very large neurons in the mouse brain
The genetically-directed sparse labeling method described here has the potential to reveal the morphologies of neurons that would be difficult to visualize by classical cell filling methods due to their low abundance and/or large arbor size. To explore this potential, we have examined large neurons that were AP-labeled in mice carrying IRES-CreER inserted in the ChAT, NFL, or TH genes.
Figure 5A–P shows a single hemisphere from a ChAT-IRES-CreER;Z/AP brain in which all AP-labeled processes were traced in a series of 16 contiguous 300 um sections. Sixteen AP labeled neurons are color-coded. Sample images of the AP-stained tissue are shown in Figures 4E and 5Q–S, and correspond to the boxed and lettered regions in Figure 5D and J. The dendritic processes of four AP-labeled neurons in the basal forebrain were not clearly separable; these dendrites are colored purple in Figure 5C–E. Five other AP-labeled neurons, such as the one pictured in Figure 5R, have dendritic arbors that are too dense to accurately trace; these are represented as grey territories in Figure 5A–H. The tracings in Figure 5 show one large neuron with cortical arbors color-coded blue (Figure 5A–H) and a second one color-coded red (Figure 5B–N); each has an extensive axonal arbor in the cortex and a cell body in the basal forebrain with a small number of branching dendrites. For the two large neurons that are color-coded green and purple, the locations of the corresponding cell bodies could not be identified unambiguously. A striking observation from this set of tracings is that single cholinergic neurons possess arbors that ramify through nearly the full thickness of the cortex and extend across >2 mm2 of cortical surface. The cortical arbors of the neurons color coded in blue, green, red, and purple in Figure 5 span, respectively, ∼2.1 mm, ∼3.3 mm, ∼2.1 mm, and ∼3.9 mm along the rostro-caudal axis.
Different neurons are color-coded. The mouse received injections of 4HT on P8 (1 mg), P21 (2 mg), and P28 (2 mg). A–P, tracing of neuronal processes from 16 serial 300 um coronal sections. Q–S and Figure 4E show bright field images of the AP-stained tissue corresponding to the boxed and lettered regions in D and J. All of the AP-stained neurons within the 16 sections are shown. Regions in which a high density of AP-labeled processes precluded accurate tracing are indicated by a semi-opaque grey zone, as shown for the cell in panel R. Cells bodies are indicated by black arrows. Scale bars: 0.2 mm in Q and R, 0.5 mm in S.
In the hemisphere shown in Figure 5, several contiguous zones encompassing ∼50% of the cortex are devoid of AP-labeled processes, and in the contralateral hemisphere of this brain ∼80% of the cortex is devoid of AP label (data not shown). A similar pattern of large and spatially clustered AP-labeled arbors was observed in other sparsely labeled ChAT-IRES-CreER;Z/AP brains (Figure 6). The spatial clustering of AP-labeled cortical processes implies that these processes derive from a very small number of neurons.
The mouse received injections of 4HT on P8 (1 mg), P21 (2 mg), and P28 (2 mg). A,B, bright field images of AP-stained tissue corresponding to the boxed regions in J and E, respectively. C–M, AP-labeled processes traced from eleven serial 300 um coronal sections. Two adjacent neurons with cell bodies in the basal forebrain (black arrows in panels K and L) and their large axon arbors in the cerebral cortex are shown in red. All other processes are shown in green. Regions in which a high density of AP-labeled processes precluded accurate tracing are marked by semi-opaque grey zones. Scale bar: 0.5 mm in A, 0.2 mm in B.
Sparse neuronal labeling was also observed in the TH-IRES-CreER;Z/AP line following a single injection of 0.2 mg 4HT at P1. Figure 7 shows a single AP-labeled projection neuron in a series of 15 contiguous 300 um sections from a brain that contained only two AP-labeled cells; the second AP-labeled neuron was present in the contralateral hemisphere and is not shown here. The cell body of the AP-labeled neuron pictured in Figure 7 resides in the periaqueductal gray (arrow in Figure 7N), and its axon sends out branches along ∼3 mm of its >3.6 mm rostral trajectory. The most extensive branching is in the lateral hypothalamus (Figure 7C–F), a major target for projection neurons with cell bodies residing in the periaqueductal gray .
A–O, Fifteen serial 300 um coronal sections. This is the only AP-expressing neuron in this hemisphere. The cell body is indicated by the black arrow in N.
In NFL-IRES-CreER;Z/AP mice that received a single 0.2 mg injection of 4HT at P0, the left and right hippocampi typically show highly asymmetric patterns of AP-labeling. For example, in the serial 300 um coronal sections in Figure 8, in which all of the AP-labeled processes in the hippocampus have been traced, almost all of the AP-labeling is unilateral. These AP-labeled processes comprise a contiguous and extensively ramifying arbor near the surface of the molecular layer of the dentate gyrus that encompasses the full rostro-caudal extent of the hippocampus. The absence of other AP-labeled processes over most of the hippocampus argues that the contiguous processes derive from a very small number of cells, and quite possibly a single cell. In a set of seven NFL-IRES-CreER;Z/AP brains with similarly sparse labeling, AP-labeling within the hippocampus was confined to a small number of compact pyramidal or granule neurons and/or to large arbors similar to the one shown in Figure 8. In this set, two, three, and two brains exhibited AP-labeling of the type shown in Figure 8 within both, only one, or neither hippocampus, respectively. Within each brain with AP-labeled hippocampi, the labeled processes occupied a contiguous territory. The spatial clustering of AP-labeled processes within the hippocampus is consistent with the inference that each contiguous AP-labeled arbor is likely derived from a single neuron.
A–L, Contiguous AP-labeled processes span eleven serial 300 um sections within the hippocampus. All of the AP labeled processes within the two hippocampi have been traced, but AP-labeled neurons outside of the hippocampus are not shown. M, anterior hippocampus corresponding to the boxed region in B shows unilateral AP-labeling. Some residual endogenous alkaline phosphatase activity is seen in the vasculature and choroid plexus. The cell body of this neuron has not been localized. N,O, Two images from a Z-stack of the region bounded by the pair of black corner marks in M. The processes of the AP-labeled neuron form a finely spaced meshwork near the surface of the molecular layer of the dentate gyrus. Scale bars: 0.5 mm in M, 0.2 mm in O.
The location, structure, and size of the large AP-labeled hippocampal arbors closely resemble the arbors of large hippocampal CA3 pyramidal neurons visualized by HRP, biocytin, and neurobiotin injection –. Although it is uncertain whether arbor filling was complete in all of these earlier studies, the different studies are in overall agreement with respect to the large size, extensive branching, and overall appearance of these arbors.
In this paper we have used the CreER technology to non-invasively label very small numbers of neurons so that their morphologies can be fully visualized. The four lines of IRES-CreER knock-in mice described here permit labeling that is selective for cholinergic or catecholaminergic neurons (TH-IRES-CreER or ChAT-IRES-CreER), that is enriched for projection neurons (NFL-IRES-CreER), or that is broadly targeted to neurons and some glia (VAMP2-IRES-CreER). We note that in the context of typical CreER-based tissue- and time-specific conditional knockout experiments, inefficient Cre-mediated recombination of target genes is generally considered undesirable . By contrast, the strategy presented here exploits inefficient recombination to produce an extremely sparse collection of labeled neurons. As demonstrated here and in ref. 14, the number of recombined neurons can be reproducibly lowered to fewer than 50 per brain.
General properties of the CreER;Z/AP method
For genetically-directed cell labeling to be useful for the analysis of neuronal morphology, Cre-mediated recombination following 4HT exposure should label only ∼1 in 104–108 neurons, depending on CNS location. In the system described here, this inefficiency arises from a combination of four factors: (1) the relatively inefficient translation of CreER coding sequences mediated by the IRES element ; (2) a serendipitous inefficiency of recombination at the Z/AP locus that renders it ∼1,000 fold less recombinogenic than other constructs in which a pair of loxP sites directs excision of an intervening segment of several kilobases [e.g., conditional knockout alleles at the Frizzled5 locus  and at the Brn3a and Brn3b loci (T. Badea and J. Nathans, unpublished)]; (3) the dose and route of administration of 4HT; and (4) a progressive decrease in Cre-mediated recombination when 4HT is administered at later postnatal ages.
Sparse labeling also requires targeting of postmitotic cells to avoid generating clonally related clusters of neurons. For those CNS regions in which neuronal proliferation occurs prenatally (e.g. the cerebral cortex) this is readily achieved by 4HT injection at any postnatal age; for those regions in which neuronal proliferation continues postnatally (e.g. retina and cerebellum) 4HT injection can be delayed until ∼P8–P10. Furthermore, since expression of the ChAT, NFL, and TH genes is low or undetectable in proliferating progenitors, Cre-mediated recombination in the corresponding IRES-CreER knock-in lines should also be low in proliferating progenitors regardless of the time of 4HT injection. By contrast, in the case of VAMP2-IRES-CreER;Z/AP mice, 4HT injection at P2 produced clones of several hundred granule cells in the cerebellum (data not shown), implying expression of CreER from the VAMP2 locus in proliferating granule cell progenitors.
Two properties of AP histochemistry are particularly useful for the morphologic analysis of large neurons: (1) efficient diffusion of the low-molecular weight histochemical substrates into fixed tissue and (2) the stability of the AP reaction product, which survives immersion in the tissue clearing agent benzylbenzoate∶benzyl alcohol (BBBA). These attributes of substrate and product permit processing and imaging of a small number of relatively thick sections (200–400 um thickness), thus minimizing the technically challenging alignment of neuronal processes between sections. We also note that the NBT/BCIP precipitate does not bleach or fade with visible light exposure and, if the tissue is stored in ethanol, the precipitate can be preserved for years with no apparent loss or diffusion. These attributes facilitate data collection over many imaging sessions. Although not utilized in the present study, AP activity can also be visualized by transmission electron microscopy via the production of a lead-phosphate precipitate, thus facilitating a correlation between light microscopic and ultrastructural analyses .
Large size and complex morphology of basal forebrain cholinergic neurons
Cholinergic neurons with cell bodies located in the basal forebrain modulate cellular activity throughout the cerebral cortex, with wide-ranging physiologic effects. For example, cholinergic input modifies the response properties of neurons in primary sensory cortices, enhances the response to behaviorally significant stimuli in association areas, facilitates cortical control of motor output, and regulates vascular tone , . Current evidence supports a model in which cholinergic neurotransmission modulates neuronal excitability but does not carry point-to-point information as glutamatergic and GABAergic transmission does .
Interest in the forebrain cholinergic system has been greatly stimulated by the observation that postmortem Alzheimer's disease brains exhibit a decrease in the number of cell bodies of cholinergic neurons in the basal forebrain and a parallel loss of enzymes involved in cholinergic transmission (e.g. ChAT) in the cerebral cortex –. Similar losses have also been reported in patients with Down syndrome, Parkinson's disease, and a variety of other progressive dementias , , . These findings have led to the development of drugs to enhance cholinergic transmission as a strategy to partially ameliorate disease symptoms in patients with these disorders .
Sparse Cre-mediated recombination in ChAT-IRES-CreER;Z/AP mice permits the visualization of the full axonal and dendritic arbors of individual forebrain cholinergic neurons. To the best of our knowledge, this is the first time that the complete morphology of these cells has been revealed in any species. Earlier studies in which individual basal forebrain cholinergic neurons were labeled by injection of neurobiotin revealed their dendritic arbors but only incompletely filled their much larger axonal arbors . The striking finding from the present study is that, for an individual cholinergic neuron, the axonal arbor is extremely large, with dense ramifications over a cortical surface area of >2 mm2 in the mouse. The large size of these cells is consistent with the simple idea that their loss in a variety of degenerative CNS diseases might reflect a correspondingly high metabolic burden and/or a high burden of toxic insults from amyloid deposition or reactive chemical species. Ideas along these lines have gained wide currency in the context of motor neuron disease and peripheral sensory neuropathies, with the enhanced susceptibility to disease in these contexts being related to the presence of an extremely long axon .
Implications for visualizing neuronal morphology and sub-cellular structure
The most widely used methods for defining the morphologies of individual mammalian neurons involve fluorescent dye or neurobiotin filling by intracellular injection. In the simplest version of these methods, each neuron is identified solely on the basis of properties that are revealed after micro-electrode penetration: morphology, physiology, or both. However, this approach is extremely tedious if the goal is to target a particular neuronal subset, and it is impractical if that subset is rare.
A more efficient derivative of this method takes advantage of nondestructive approaches that reveal particular neuronal subsets in living tissue to guide intracellular tracer injection. For example, a particular subset of cell bodies can be visualized by retrograde labeling with fluorescent dextran, a method that has been widely used to analyze the morphologies of retinal ganglion cells that project to defined retinorecipient areas in the brain [e.g. ref. 2]. Alternatively, a subset of cell bodies can be visualized based on expression of a fluorescent protein marker . The critical constraint in this more sophisticated approach to tracer injection is the requirement for optical access, making it practical for slice preparations, retinal flat mounts, or the more superficial layers of the cerebral cortex, but impractical for deeper brain regions. By contrast, the genetic alternative to tracer injection reveals neuronal morphologies based solely on sparse cell-type specific expression of a reporter.
The sparse labeling approach described here can be easily extended to Cre-control of other proteins. An especially interesting extension involves producing fluorescent fusion proteins that localize to subcellular structures such as synapses, mitochondria, or the cytoskeleton. This type of labeling has recently been reported following biolistic transformation of neurons in retina explants , . Extending this analysis to neurons labeled in vivo by CreER-mediated activation of germline reporters would be particularly interesting in the context of CNS disease models.
Genomic DNA segments encompassing the 3′ most exons of the mouse ChAT, NFL, TH, and VAMP2 genes were isolated from an ES cell genomic library in bacteriophage lambda (a gift of Dr. Se-Jin Lee). For each knock-in allele, a cassette consisting of an IRES-CreER, the pBR322 tetracycline resistance gene (TetR), and a Frt-flanked phosphoglycerate kinase promotor-neomycin resistance gene (FNF) was inserted into the 3′ untranslated region within a genomic segment that had been subcloned into a plasmid carrying a Herpes Simplex Virus thymidine kinase gene. The TetR gene was included within the IRES-CreER/FNF cassette to facilitate identification of the final plasmid construct. The restriction site in the 3′ UTR into which the IRES-CreER/TetR/FNF cassette was inserted, together with the sequence of ten nucleotides on each side of the insertion sites are as follows. ChAT: Sac I, GGGCTGGGAGCTCCCTCTGA; NFL: Pci I, AGTCAATACATGTATAATTC; TH: Acc65 I, TGCATAGGGTACCACCCACA; VAMP2: BamH I, CTCCCTTGGATCCGTGTGTG. Following electroporation into ES cells and positive and negative selection (G418 and gancyclovir, respectively), colonies were screened by Southern blot hybridization with ∼500 bp probes generated by PCR as shown in Figure 1. Karyotypically normal ES cells were used for blastocyst injection.
Following germline transmission of the targeted allele, the PGK-neo cassette was excised by crossing to mice expressing Flp in the germline. Lines were maintained on a mixed Sv129×C57BL/6 background. VAMP2-IRES-CreER homozygotes are inviable, but the other three IRES-CreER lines can be maintained as homozygous stocks. All four lines have been deposited at the Jackson Laboratories and are freely available. Mice were handled and housed in accordance with the Johns Hopkins University Animal Care and Use Protocols and IACUC guidelines.
As shown in Figure 1 and Table 1, PCR genotyping with a sense strand TetR primer (primer C), a sense strand 3′ UTR primer 5′ of the IRES-CreER/TetR insertion site (primer A) and a 3′ UTR antisense primer 3′ of the IRES-CreER/TetR insertion site (primer B) produces PCR products of different size for the untargeted allele and the knock-in allele, thus distinguishing homozygous WT, heterozygote, and homozygous knock-in genotypes. PCR was performed with Advantage 2 Polymerase (Clontech, La Jolla, CA) using 35 cycles of 30 seconds denaturation at 94°C, 30 second annealing at 60°C, and 1 minute elongation at 72°C. Rapid testing for the presence of the Z/AP allele was performed by X-gal staining of a small piece of tail.
4HT injection and tissue processing
These procedures were performed essentially as described in ref. 14. In brief, 4HT was dissolved in ethanol, mixed with sunflower seed oil (Sigma, St. Louis, MO), centrifuged under vacuum to remove the ethanol, and delivered as a single intraperitoneal injection between P0 and P10 at a dose of 0.05–0.4 mg per mouse. After at least one month, the mice were anesthetized, and subjected to transcardiac perfusion with 4% paraformaldehyde in PBS. The brain was set in a block of 3% standard or low-melting point agarose in PBS and a complete series of 300 um coronal sections were cut with a vibratome. Brain sections and intact retinas in PBS were heated in a water bath at 65°C for 75 minutes to inactivate endogenous AP and, for those embedded in low melting point agarose, to melt the agarose surrounding the tissue; heat-inactivated tissues were then reacted in NBT/BCIP overnight at room temperature with gentle agitation. After washing and post-fixation, tissues were dehydrated with a graded ethanol series, and clarified in 2∶1 benzylbenzoate∶benzyl alcohol (BBBA). For long-term storage, tissue samples were returned to ethanol. AP-stained tissues can be stored in ethanol for several years with no change in appearance.
Microscopy and neurite tracing
Images were captured on a Zeiss Stemi SV11 dissecting microscope equipped with OpenLab software and a Zeiss Axio Imager Z1 microscope equipped with a motorized stage and AxioVision software. Typically, 1 um or 2 um Z-steps were used to capture grey-scale bright-field or DIC images. As BBBA leads to tissue shrinkage of circa 30%, a complete Z-stack at 2 um intervals of what was initially a 300 um section can be captured with ∼100 images; the size of the resulting image stack is ∼180 Mbytes. For each vibratome section, a two-dimensional projection of AP-labeled neurites was obtained by manually tracing over the electronic images using an electronic stylus (Wacom, Saltama, Japan) and Illustrator CS2 software.
The authors thank Chip Hawkins for blastocyst injections, Tudor Badea for advice, Stephen Berger for assistance with cell tracing, and Tudor Badea, Chunqiao Liu, and Amir Rattner for helpful comments on the manuscript.
Conceived and designed the experiments: TR JN. Performed the experiments: TR PMS JW JN. Analyzed the data: JN. Wrote the paper: JN.
- 1. Ramon y Cajal S (1911) Histologie du systeme nerveux de l'homme at des vertebras. S. Ramon y Cajal1911Histologie du systeme nerveux de l'homme at des vertebras.Paris: Maloine; reprinted 1955, Madrid: Instituto Ramon y Cajal. Paris: Maloine; reprinted 1955, Madrid: Instituto Ramon y Cajal.
- 2. Leventhal AG, Rodieck RW, Dreher B (1985) Central projections of cat retinal ganglion cells. J Comp Neurol 237: 216–226.AG LeventhalRW RodieckB. Dreher1985Central projections of cat retinal ganglion cells.J Comp Neurol237216226
- 3. Gan WB, Grutzendler J, Wong WT, Wong RO, Lichtman JW (2000) Multicolor “DiOlistic” labeling of the nervous system using lipophilic dye combinations. Neuron 27: 219–225.WB GanJ. GrutzendlerWT WongRO WongJW Lichtman2000Multicolor “DiOlistic” labeling of the nervous system using lipophilic dye combinations.Neuron27219225
- 4. Dacey DM, Peterson BB, Robinson FR, Gamlin PD (2003) Fireworks in the primate retina: in vitro photodynamics reveals diverse LGN-projecting ganglion cell types. Neuron 37: 15–27.DM DaceyBB PetersonFR RobinsonPD Gamlin2003Fireworks in the primate retina: in vitro photodynamics reveals diverse LGN-projecting ganglion cell types.Neuron371527
- 5. Szmajda BA, Grünert U, Martin PR (2008) Retinal ganglion cell inputs to the koniocellular pathway. J Comp Neurol 510: 251–268.BA SzmajdaU. GrünertPR Martin2008Retinal ganglion cell inputs to the koniocellular pathway.J Comp Neurol510251268
- 6. Dacey DM, Lee BB (1994) The ‘blue-on’ opponent pathway in primate retina originates from a distinct bistratified ganglion cell type. Nature 367: 731–735.DM DaceyBB Lee1994The ‘blue-on’ opponent pathway in primate retina originates from a distinct bistratified ganglion cell type.Nature367731735
- 7. Moriyoshi K, Richards LJ, Akazawa C, O'Leary DD, Nakanishi S (1996) Labeling neural cells using adenoviral gene transfer of membrane-targeted GFP. Neuron 16: 255–260.K. MoriyoshiLJ RichardsC. AkazawaDD O'LearyS. Nakanishi1996Labeling neural cells using adenoviral gene transfer of membrane-targeted GFP.Neuron16255260
- 8. Wellmann H, Kaltschmidt B, Kaltschmidt C (1999) Optimized protocol for biolistic transfection of brain slices and dissociated cultured neurons with a hand-held gene gun. J Neurosci Methods 92: 55–64.H. WellmannB. KaltschmidtC. Kaltschmidt1999Optimized protocol for biolistic transfection of brain slices and dissociated cultured neurons with a hand-held gene gun.J Neurosci Methods925564
- 9. D'Apuzzo M, Mandolesi G, Reis G, Schuman EM (2001) Abundant GFP expression and LTP in hippocampal acute slices by in vivo injection of sindbis virus. J Neurophysiol 86: 1037–1042.M. D'ApuzzoG. MandolesiG. ReisEM Schuman2001Abundant GFP expression and LTP in hippocampal acute slices by in vivo injection of sindbis virus.J Neurophysiol8610371042
- 10. Bestman JE, Ewald RC, Chiu SL, Cline HT (2006) In vivo single-cell electroporation for transfer of DNA and macromolecules. Nature Protoc 1: 1267–1272.JE BestmanRC EwaldSL ChiuHT Cline2006In vivo single-cell electroporation for transfer of DNA and macromolecules.Nature Protoc112671272
- 11. Lee T, Luo L (1999) Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis. Neuron 22: 451–461.T. LeeL. Luo1999Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis.Neuron22451461
- 12. Zong H, Espinosa JS, Su HH, Muzumdar MD, Luo L (2005) Mosaic analysis with double markers in mice. Cell 121: 479–492.H. ZongJS EspinosaHH SuMD MuzumdarL. Luo2005Mosaic analysis with double markers in mice.Cell121479492
- 13. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, et al. (1996) Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA 93: 10887–10890.R. FeilJ. BrocardB. MascrezM. LeMeurD. Metzger1996Ligand-activated site-specific recombination in mice.Proc Natl Acad Sci USA931088710890
- 14. Badea T, Wang Y, Nathans J (2003) A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse. J Neurosci 23: 2314–2322.T. BadeaY. WangJ. Nathans2003A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse.J Neurosci2323142322
- 15. Badea T, Nathans J (2004) Quantitative analysis of neuronal morphologies in the mouse retina visualized using a genetically directed reporter. J Comp Neurol 480: 331–351.T. BadeaJ. Nathans2004Quantitative analysis of neuronal morphologies in the mouse retina visualized using a genetically directed reporter.J Comp Neurol480331351
- 16. Kim IJ, Zhang Y, Yamagata M, Meister M, Sanes JR (2008) Molecular identification of a retinal cell type that responds to upward motion. Nature 452: 478–482.IJ KimY. ZhangM. YamagataM. MeisterJR Sanes2008Molecular identification of a retinal cell type that responds to upward motion.Nature452478482
- 17. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, et al. (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28: 41–51.G. FengRH MellorM. BernsteinC. Keller-PeckQT Nguyen2000Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP.Neuron284151
- 18. Livet J, Weissman TA, Kang H, Draft RW, Lu J, et al. (2007) Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450: 56–62.J. LivetTA WeissmanH. KangRW DraftJ. Lu2007Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system.Nature4505662
- 19. Young P, Qiu L, Wang D, Zhao S, Gross J, Feng G (2008) Single-neuron labeling with inducible Cre-mediated knockout in transgenic mice. Nat Neurosci 11: 721–728.P. YoungL. QiuD. WangS. ZhaoJ. GrossG. Feng2008Single-neuron labeling with inducible Cre-mediated knockout in transgenic mice.Nat Neurosci11721728
- 20. Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, et al. (2003) A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425: 917–925.S. GongC. ZhengML DoughtyK. LososN. Didkovsky2003A gene expression atlas of the central nervous system based on bacterial artificial chromosomes.Nature425917925
- 21. Gong S, Doughty M, Harbaugh CR, Cummins A, Hatten ME, et al. (2007) Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. J Neurosci 27: 9817–9823.S. GongM. DoughtyCR HarbaughA. CumminsME Hatten2007Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs.J Neurosci2798179823
- 22. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, et al. (1999) Z/AP, a double reporter for cre-mediated recombination. Dev Biol 208: 281–292.CG LobeKE KoopW. KreppnerH. LomeliM. Gertsenstein1999Z/AP, a double reporter for cre-mediated recombination.Dev Biol208281292
- 23. Fields-Berry SC, Halliday AL, Cepko CL (1992) A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina. Proc Natl Acad Sci USA 89: 693–697.SC Fields-BerryAL HallidayCL Cepko1992A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina.Proc Natl Acad Sci USA89693697
- 24. Wong YW, Low MG (1994) Biosynthesis of glycosylphosphatidylinositol-anchored human placental alkaline phosphatase: evidence for a phospholipase C-sensitive precursor and its post-attachment conversion into a phospholipase C-resistant form. Biochem J 301: 205–209.YW WongMG Low1994Biosynthesis of glycosylphosphatidylinositol-anchored human placental alkaline phosphatase: evidence for a phospholipase C-sensitive precursor and its post-attachment conversion into a phospholipase C-resistant form.Biochem J301205209
- 25. Peichl L, González-Soriano J (1993) Unexpected presence of neurofilaments in axon-bearing horizontal cells of the mammalian retina. J Neurosci 13: 4091–4100.L. PeichlJ. González-Soriano1993Unexpected presence of neurofilaments in axon-bearing horizontal cells of the mammalian retina.J Neurosci1340914100
- 26. Famiglietti EV Jr (1983) On and off pathways through amacrine cells in mammalian retina: the synaptic connections of “starburst” amacrine cells. Vision Res 23: 1265–1279.EV Famiglietti Jr1983On and off pathways through amacrine cells in mammalian retina: the synaptic connections of “starburst” amacrine cells.Vision Res2312651279
- 27. Gustincich S, Feigenspan A, Wu DK, Koopman LJ, Raviola E (1997) Control of dopaminergic release in the retina: a transgenic approach to neural networks. Neuron 18: 723–736.S. GustincichA. FeigenspanDK WuLJ KoopmanE. Raviola1997Control of dopaminergic release in the retina: a transgenic approach to neural networks.Neuron18723736
- 28. Tsiola A, Hamzei-Sichani F, Peterlin Z, Yuste R (2003) Quantitative morphologic classification of layer 5 neurons from mouse primary visual cortex. J Comp Neurol 461: 415–428.A. TsiolaF. Hamzei-SichaniZ. PeterlinR. Yuste2003Quantitative morphologic classification of layer 5 neurons from mouse primary visual cortex.J Comp Neurol461415428
- 29. Beitz AJ (1995) Periaqueductal Gray. In: Paxinos G, editor. The Rat Nervous System. New York: Academic Press. pp. 173–182.AJ Beitz1995Periaqueductal Gray.G. PaxinosThe Rat Nervous SystemNew YorkAcademic Press173182
- 30. Sik A, Tamamaki N, Freund TF (1993) Complete axon arborization of a single CA3 pyramidal cell in the rat hippocampus, and its relationship with postsynaptic parvalbumin-containing interneurons. Eur J Neurosci 5: 1719–1728.A. SikN. TamamakiTF Freund1993Complete axon arborization of a single CA3 pyramidal cell in the rat hippocampus, and its relationship with postsynaptic parvalbumin-containing interneurons.Eur J Neurosci517191728
- 31. Li XG, Somogyi P, Ylinen A, Buzsáki G (1994) The hippocampal CA3 network: an in vivo intracellular labeling study. J Comp Neurol 339: 181–208.XG LiP. SomogyiA. YlinenG. Buzsáki1994The hippocampal CA3 network: an in vivo intracellular labeling study.J Comp Neurol339181208
- 32. Wittner L, Henze DA, Záborszky L, Buzsáki G (2007) Three-dimensional reconstruction of the axon arbor of a CA3 pyramidal cell recorded and filled in vivo. Brain Struct Funct 212: 75–83.L. WittnerDA HenzeL. ZáborszkyG. Buzsáki2007Three-dimensional reconstruction of the axon arbor of a CA3 pyramidal cell recorded and filled in vivo.Brain Struct Funct2127583
- 33. Hayashi S, McMahon AP (2002) Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 244: 305–318.S. HayashiAP McMahon2002Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.Dev Biol244305318
- 34. Ngoi SM, Chien AC, Lee CG (2004) Exploiting internal ribosome entry sites in gene therapy vector design. Curr Gene Ther 4: 15–31.SM NgoiAC ChienCG Lee2004Exploiting internal ribosome entry sites in gene therapy vector design.Curr Gene Ther41531
- 35. Liu C, Wang Y, Smallwood PM, Nathans J (2008) An essential role for Frizzled5 in neuronal survival in the parafascicular nucleus of the thalamus. J Neurosci 28: 5641–5653.C. LiuY. WangPM SmallwoodJ. Nathans2008An essential role for Frizzled5 in neuronal survival in the parafascicular nucleus of the thalamus.J Neurosci2856415653
- 36. Lucas-Meunier E, Fossier P, Baux G, Amar M (2003) Cholinergic modulation of the cortical neuronal network. Pflugers Arch 446: 17–29.E. Lucas-MeunierP. FossierG. BauxM. Amar2003Cholinergic modulation of the cortical neuronal network.Pflugers Arch4461729
- 37. Hamel E (2004) Cholinergic modulation of the cortical microvascular bed. Prog. Brain Res 145: 171–178.E. Hamel2004Cholinergic modulation of the cortical microvascular bed. Prog.Brain Res145171178
- 38. Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403.P. DaviesAJ Maloney1976Selective loss of central cholinergic neurons in Alzheimer's disease.Lancet21403
- 39. Price DL, Koliatsos VE, Clatterbuck RC (1993) Cholinergic systems: human diseases, animal models, and prospects for therapy. Prog Brain Res 98: 51–60.DL PriceVE KoliatsosRC Clatterbuck1993Cholinergic systems: human diseases, animal models, and prospects for therapy.Prog Brain Res985160
- 40. Wainer BH, Steininger TL, Roback JD, Burke-Watson MA, Mufson EJ, et al. (1993) Ascending cholinergic pathways: functional organization and implications for disease models. Prog Brain Res 98: 9–30.BH WainerTL SteiningerJD RobackMA Burke-WatsonEJ Mufson1993Ascending cholinergic pathways: functional organization and implications for disease models.Prog Brain Res98930
- 41. Auld DS, Kornecook TJ, Bastianetto S, Quirion R (2002) Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68: 209–245.DS AuldTJ KornecookS. BastianettoR. Quirion2002Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.Prog Neurobiol68209245
- 42. Yates CM, Simpson J, Maloney AF, Gordon A, Reid AH (1980) Alzheimer-like cholinergic deficiency in Down syndrome. Lancet 2: 979.CM YatesJ. SimpsonAF MaloneyA. GordonAH Reid1980Alzheimer-like cholinergic deficiency in Down syndrome.Lancet2979
- 43. Whitehouse PJ, Hedreen JC, White CL 3rd, Price DL (1983) Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 13: 243–248.PJ WhitehouseJC HedreenCL White 3rdDL Price1983Basal forebrain neurons in the dementia of Parkinson disease.Ann Neurol13243248
- 44. Burns A, O'Brien J, Auriacombe S, Ballard C, et al. BAP Dementia Consensus group (2006) Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol 20: 732–755.A. BurnsJ. O'BrienS. AuriacombeC. BallardBAP Dementia Consensus group2006Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.J Psychopharmacol20732755
- 45. Duque A, Tepper JM, Detari L, Ascoli GA, Zaborszky L (2007) Morphological characterization of electrophysiologically and immunohistochemically identified basal forebrain cholinergic and neuropeptide Y-containing neurons. Brain Struct Funct 212: 55–73.A. DuqueJM TepperL. DetariGA AscoliL. Zaborszky2007Morphological characterization of electrophysiologically and immunohistochemically identified basal forebrain cholinergic and neuropeptide Y-containing neurons.Brain Struct Funct2125573
- 46. Fischer LR, Glass JD (2007) Axonal degeneration in motor neuron disease. Neurodegener Dis 4: 431–442.LR FischerJD Glass2007Axonal degeneration in motor neuron disease.Neurodegener Dis4431442
- 47. van den Pol AN, Acuna-Goycolea C, Clark KR, Ghosh PK (2004) Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron 42: 635–652.AN van den PolC. Acuna-GoycoleaKR ClarkPK Ghosh2004Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection.Neuron42635652
- 48. Jakobs TC, Koizumi A, Masland RH (2008) The spatial distribution of glutamatergic inputs to dendrites of retinal ganglion cells. J Comp Neurol 510: 221–236.TC JakobsA. KoizumiRH Masland2008The spatial distribution of glutamatergic inputs to dendrites of retinal ganglion cells.J Comp Neurol510221236
- 49. Morgan JL, Schubert T, Wong RO (2008) Developmental patterning of glutamatergic synapses onto retinal ganglion cells. Neural Develop 3: 8.JL MorganT. SchubertRO Wong2008Developmental patterning of glutamatergic synapses onto retinal ganglion cells.Neural Develop38